Epizyme Announces 2013 Operating and Financial Results and Provides 2014 Guidance

[PR Newswire] – CAMBRIDGE, Mass., Feb. 27, 2014 /PRNewswire/ — Epizyme, Inc. (NASDAQ: EPZM), a clinical stage biopharmaceutical company creating innovative personalized therapeutics for patients with genetically defined … more

View todays social media effects on EPZM

View the latest stocks trending across Twitter. Click to view dashboard

See who Epizyme is hiring next, click here to view